Compliance Resources
MD Labs is committed to having a Gold Standard Compliance Program. In accordance with the recommendation made by the Office of the Inspector General (OIG), as part of our Compliance Program annual review, below are our most current policies and related forms.
MD Labs 2023 Payers Requiring Signed Requisition & Medical Records
MD Labs 2023 Financial Assistance Disclosure Application (FADA)
MD Labs 2023 Certification of Determination of Financial Need & Request to Offer Patient Discount
MD Labs 2023 Revocation of Patient Election to Self-Pay for Services
Advance Beneficiary Notice of Noncoverage (ABN) Form Instructions
MD Labs 2023 Request for Additional Information Form & Instructions
Important Compliance Links
Below are important compliance links, as specified in the 2023 Referring Providers Annual Notice.
PECOS
More information on PECOS and how to enroll in the system may be viewed at:
False Claim Act
The Office of Inspector General (OIG) takes the position that physicians or other individuals authorized by law to order laboratory tests, who knowingly cause a false claim submission to any federally funded program, may be subject to sanctions or remedies available under civil, criminal, and administrative law, such as the False Claims Act.
Medicare Program Integrity Manual
Centers for Medicare & Medicaid Services (CMS) provides signature requirements guidance via CMS Change Request CR9225, CR9332:
The 2023 Medicare Clinical Laboratory Fee Schedule
The 2022 Medicare Clinical Laboratory Fee schedule may be viewed and downloaded at:
Local Coverage Determinations (LCD) guidelines and Medicare Coverage Articles, Noridian, LLC, a Nevada Medicare Part B carrier
Local Coverage Determinations (LCD) guidelines may supplement or be in addition to the National Coverage Determinations and give direction for medical necessity on selected tests.
Medicare LCD #36668: Controlled Substance Monitoring and Drugs of Abuse Testing
Medicare Coverage Article #A55001: Controlled Substance Monitoring and Drugs of Abuse Testing
Other laboratory LCDs and Medicare Coverage Articles are available at:
Advance Beneficiary Notice of Noncoverage (ABN)
Please find additional information about ABNs at:
Compliance with Federal Beneficiary Inducement Statute, Anti-Kickback Statute, Stark Law and EKRA
MD Labs' policy is to fully comply with the Medicare Beneficiary Inducement Statute, Anti-Kickback Statute (AKS), Stark Law, and Eliminating Kickback in Recovery Act (EKRA). Please review the following web pages for more information: